239 related articles for article (PubMed ID: 12504074)
1. A review of the effect of atypical antipsychotics on weight.
Nasrallah H
Psychoneuroendocrinology; 2003 Jan; 28 Suppl 1():83-96. PubMed ID: 12504074
[TBL] [Abstract][Full Text] [Related]
2. Tolerability of atypical antipsychotics.
Stanniland C; Taylor D
Drug Saf; 2000 Mar; 22(3):195-214. PubMed ID: 10738844
[TBL] [Abstract][Full Text] [Related]
3. Benefit-risk assessment of atypical antipsychotics in the treatment of schizophrenia and comorbid disorders in children and adolescents.
Toren P; Ratner S; Laor N; Weizman A
Drug Saf; 2004; 27(14):1135-56. PubMed ID: 15554747
[TBL] [Abstract][Full Text] [Related]
4. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
5. Quetiapine versus other atypical antipsychotics for schizophrenia.
Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
[TBL] [Abstract][Full Text] [Related]
6. Safety and tolerability: how do newer generation "atypical" antipsychotics compare?
Tandon R
Psychiatr Q; 2002; 73(4):297-311. PubMed ID: 12418358
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment with atypical antipsychotics and the risk of weight gain : a literature analysis.
Gentile S
Drug Saf; 2006; 29(4):303-19. PubMed ID: 16569080
[TBL] [Abstract][Full Text] [Related]
8. Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.
Atmaca M; Kuloglu M; Tezcan E; Ustundag B
J Clin Psychiatry; 2003 May; 64(5):598-604. PubMed ID: 12755665
[TBL] [Abstract][Full Text] [Related]
9. [Metabolic side effects of risperidone in early onset schizophrenia].
Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
[TBL] [Abstract][Full Text] [Related]
10. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.
Newcomer JW
CNS Drugs; 2005; 19 Suppl 1():1-93. PubMed ID: 15998156
[TBL] [Abstract][Full Text] [Related]
11. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
12. Bodyweight gain with atypical antipsychotics. A comparative review.
Wetterling T
Drug Saf; 2001 Jan; 24(1):59-73. PubMed ID: 11219487
[TBL] [Abstract][Full Text] [Related]
13. Aripiprazole versus other atypical antipsychotics for schizophrenia.
Khanna P; Komossa K; Rummel-Kluge C; Hunger H; Schwarz S; El-Sayeh HG; Leucht S
Cochrane Database Syst Rev; 2013 Feb; (2):CD006569. PubMed ID: 23450570
[TBL] [Abstract][Full Text] [Related]
14. Weight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance, and management.
Stigler KA; Potenza MN; Posey DJ; McDougle CJ
Paediatr Drugs; 2004; 6(1):33-44. PubMed ID: 14969568
[TBL] [Abstract][Full Text] [Related]
15. The implications of weight changes with antipsychotic treatment.
Sussman N
J Clin Psychopharmacol; 2003 Jun; 23(3 Suppl 1):S21-6. PubMed ID: 12832946
[TBL] [Abstract][Full Text] [Related]
16. Tolerability profile of atypical antipsychotics in children and adolescents.
Stigler KA; Potenza MN; McDougle CJ
Paediatr Drugs; 2001; 3(12):927-42. PubMed ID: 11772153
[TBL] [Abstract][Full Text] [Related]
17. Weight gain and antipsychotic medication: differences between antipsychotic-free and treatment periods.
Simpson MM; Goetz RR; Devlin MJ; Goetz SA; Walsh BT
J Clin Psychiatry; 2001 Sep; 62(9):694-700. PubMed ID: 11681765
[TBL] [Abstract][Full Text] [Related]
18. Treatment of bipolar mania with atypical antipsychotics.
Chengappa KN; Suppes T; Berk M
Expert Rev Neurother; 2004 Nov; 4(6 Suppl 2):S17-25. PubMed ID: 16279862
[TBL] [Abstract][Full Text] [Related]
19. A review of atypical antipsychotic drugs versus conventional medication in schizophrenia.
Luft B; Taylor D
Expert Opin Pharmacother; 2006 Sep; 7(13):1739-48. PubMed ID: 16925501
[TBL] [Abstract][Full Text] [Related]
20. Choosing an atypical antipsychotic.
Sussman N
Int Clin Psychopharmacol; 2002 Aug; 17 Suppl 3():S29-33. PubMed ID: 12570069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
